Malignant irreversible intestinal obstruction: the powerful association of octreotide to corticosteroids, antiemetics, and analgesics

Published on Thursday, 12 November 2015


In the case of malignant intestinal obstruction, surgery often carries important mortality and morbidity risks, and feasibility is neither realistic nor reasonable.

A total of 4 clinical cases of intestinal obstruction caused by advanced gastrointestinal cancers in their terminal phase are described.

The association of analgesics, corticosteroids, antiemetics, and octreotide was effective to relieve symptoms of intestinal obstruction for the remaining lifetime.

The insertion of a nasogastric tube was avoided in 3 of 4 cases.

Death occurred 51, 56, and 64 days after clinical and radiological diagnosis of irreversible intestinal obstruction.

This combination of drugs appears very powerful and well tolerated.

The relatively long survival that was observed should encourage future studies of longer half-life somatostatin analogues with no need of continuous infusion or multiple daily injections.



About this publication.


See also Somatostatin in oncology, the overlooked evidences.